Document is current

Any future updates will be listed below

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

Crossref DOI link: https://doi.org/10.1007/s00520-016-3332-x

Published Online: 2016-08-08

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark